Target intelligence / Profile preview

Immunoglobulin lambda joining 7 (IGLJ7)

Target
IGLJ7
Molecular classification
Other (Immunoglobulin gene segment)
01

Overview

Immunoglobulin lambda joining 7 (IGLJ7) is one of several J (joining) gene segments in the immunoglobulin lambda light chain gene locus on chromosome 22q11.22[1][3]. Like other J segments, IGLJ7 is involved in the V(J) recombination process that occurs during B cell development, allowing the creation of antibody light chains with diverse antigen specificities[1][2]. Each functional immunoglobulin lambda light chain gene is generated by recombination of one variable (V), one joining (J), and one constant (C) segment. The J segments provide critical coding sequence that links the rearranged V segment to the constant region. IGLJ7 itself does not encode a protein nor does it function as a receptor, enzyme, or transporter; rather, it is a recombination element essential for antibody gene diversity and adaptive immunity[1][2].

Other names
J7IGLJ7
02

Biological functions

Immune response (as a recombination segment involved in antibody gene rearrangement)
03

Disease associations

Other (immunogenetic diversity; not directly implicated in disease, but forms part of immunoglobulin rearrangement)

Beyond the preview

Go deeper on Immunoglobulin lambda joining 7 (IGLJ7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda joining 7 (IGLJ7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call